People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Healthtech, Biotechnology, Other, AI / ML
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Acutus Medical, Inc. | — | Healthtech | Series D+ | $296.3M | $69.0M | 2022 |
| Elucid Bioimaging Inc. | — | Biotechnology | Series C | $115.8M | $200.2M | 2023 |
| Uptake Medical Corp | — | Biotechnology | Series C | $113.2M | $98.2M | 2011 |
| Proximie Ltd | — | Other | Series C | $75.0M | $896.6M | 2022 |
| ECPM Holdings, LLC | — | Other | Series B | $56.9M | $515.1M | 2014 |
| Foldax, Inc. | — | Other | Series A | $38.7M | $39.4M | 2022 |
| Tissue Differentiation Intelligence, LLC | — | AI / ML | Series A | $6.0M | $216.8M | 2017 |
Scott Huennekens at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Scott Huennekens on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin Johnson | 1 | 12 |
| Brant Heise | 1 | 10 |
| Scott Davis | 1 | 10 |
| Steven Hochberg | 1 | 9 |
| Jonathan Lim | 1 | 9 |
| John Brooks | 1 | 8 |
| George Wallace | 1 | 8 |
| Kevin Foley | 1 | 8 |
| David Gill | 1 | 8 |
| Andrew ElBardissi | 1 | 7 |
| Eric Kim | 1 | 7 |
| David Kaufman | 1 | 7 |
| Uri Geiger | 1 | 6 |
| Scott Carter | 1 | 6 |
| David Bonita | 1 | 6 |
| MARK GILREATH | 1 | 6 |
| Andrew Schiff | 1 | 5 |
| Sachin Gupta | 1 | 5 |
| RIK VANDEVENNE | 1 | 5 |
| Morteza Gharib | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.